Although it was not clinically significant, it was observed that AK5 expression decreased in metastatic cancer tissues compared to primary CRC tissues and adjacent normal tissues (P = 0.068, P = 0.218, respectively, Figures S3, S4). This evidence concerns the gene AK5 and colorectal carcinoma.